Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Frontiers in Oncology|April 7, 2023
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinomaMengxue Yu, Kaiyu Qian, Gang Wang, et al.Cancer Cell International|February 19, 2021
The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylationSiming Chen, Mengxue Yu, Lingao Ju, et al.Cancer Medicine|August 26, 2020
Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancerYejinpeng Wang, Liang Chen, Mengxue Yu, et al.Cell Death & Disease|March 5, 2021
E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stabilityHuimin Xu, Lingao Ju, Yaoyi Xiong, et al.Cell Communication and Signaling : CCS|March 16, 2021
The inhibitory effect of melatonin on human prostate cancerDexin Shen, Lingao Ju, Fenfang Zhou, et al.Nature Biotechnology|May 9, 2024
Tracking single-cell evolution using clock-like chromatin accessibility lociYu Xiao, Wan Jin, Lingao Ju, et al.The Pharmacogenomics Journal|August 7, 2024
Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomicsHouyi Wei, Zhilong Li, Kaiyu Qian, et al.Journal of Cancer|March 4, 2024
Causal association of smoking, blood lipids, and bladder cancer: Insights from a multivariable and mediation mendelian randomization investigationHouyi Wei, Xiangqun Cheng, Gang Wang, et al.Journal of Cancer|May 31, 2024
ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathwayTingjun Wang, Gang Wang, Danni Shan, et al.Cell Death & Disease|April 6, 2023
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysisDexin Shen, Zhao Deng, Wei Liu, et al.Pageof 20